1 | sysmex rd center americas | | | | | | | 4 | 1.93% |
2 | rd center americas inc | | | | | | | 4 | 1.93% |
3 | center americas inc logo | | | | | | | 2 | 0.97% |
4 | americas inc logo sysmex | | | | | | | 2 | 0.97% |
5 | inc logo sysmex rd | | | | | | | 2 | 0.97% |
6 | logo sysmex rd center | | | | | | | 2 | 0.97% |
7 | skip to content sysmex | | | | | | | 1 | 0.48% |
8 | the aim of realizing | | | | | | | 1 | 0.48% |
9 | specializing in research and | | | | | | | 1 | 0.48% |
10 | to content sysmex rd | | | | | | | 1 | 0.48% |
11 | innovation biomarker assay development | | | | | | | 1 | 0.48% |
12 | open innovation biomarker assay | | | | | | | 1 | 0.48% |
13 | development with the aim | | | | | | | 1 | 0.48% |
14 | with the aim of | | | | | | | 1 | 0.48% |
15 | preventive medicine rdca works | | | | | | | 1 | 0.48% |
16 | aim of realizing preventive | | | | | | | 1 | 0.48% |
17 | of realizing preventive medicine | | | | | | | 1 | 0.48% |
18 | realizing preventive medicine rdca | | | | | | | 1 | 0.48% |
19 | a company specializing in | | | | | | | 1 | 0.48% |
20 | to bring new clinical | | | | | | | 1 | 0.48% |
21 | bring new clinical applications | | | | | | | 1 | 0.48% |
22 | new clinical applications from | | | | | | | 1 | 0.48% |
23 | company specializing in research | | | | | | | 1 | 0.48% |
24 | americas inc rdca is | | | | | | | 1 | 0.48% |
25 | is a company specializing | | | | | | | 1 | 0.48% |
26 | established an rd center | | | | | | | 1 | 0.48% |
27 | globalized its research and | | | | | | | 1 | 0.48% |
28 | using cell protein and | | | | | | | 1 | 0.48% |
29 | development using cell protein | | | | | | | 1 | 0.48% |
30 | assay development using cell | | | | | | | 1 | 0.48% |
31 | development and established an | | | | | | | 1 | 0.48% |
32 | and established an rd | | | | | | | 1 | 0.48% |
33 | an rd center in | | | | | | | 1 | 0.48% |
34 | rdca is a company | | | | | | | 1 | 0.48% |
35 | rd center in americas | | | | | | | 1 | 0.48% |
36 | center in americas sysmex | | | | | | | 1 | 0.48% |
37 | in americas sysmex rd | | | | | | | 1 | 0.48% |
38 | americas sysmex rd center | | | | | | | 1 | 0.48% |
39 | biomarker assay development using | | | | | | | 1 | 0.48% |
40 | applications from the us | | | | | | | 1 | 0.48% |